Systems and methods for glycemic control during pump disconnection
AssigneeRoche Diagnostics Operations, Inc.
InventorsOfer Yodfat, Gali Shapira
Life of this patent
Estimating the term…
Loading patent…
AssigneeRoche Diagnostics Operations, Inc.
InventorsOfer Yodfat, Gali Shapira
Estimating the term…
Techniques and devices are described for allowing a diabetes patient to safely disconnect an insulin infusion system device for a time period. In one aspect, the techniques and devices can be implemented by receiving a maximum glucose amount, a minimum glucose amount, and a contemplated disconnection time; receiving a current glucose amount of the user; determining an expected increase in glucose of the user based on the contemplated disconnection time, an insulin sensitivity of the user and a contemplated basal insulin dose; validating the contemplated disconnection time based on at least one of the expected increase in glucose, the maximum glucose amount, and the minimum glucose amount; and, administering a therapeutic action to the user based on the validation of the contemplated disconnection time.
A method for controlled disconnection of a therapeutic treatment device comprising:
A method for controlled disconnection of a therapeutic treatment device comprising:
A method for controlled disconnection of a therapeutic treatment device comprising:
A method for controlled disconnection of a therapeutic treatment device comprising:
Dependencies are inferred from the claim text.